ArticleInternational journal of radiation oncology, biology, physics2026
Dose-Linear Energy Transfer Interactions Predict Capsular Contracture After Proton Postmastectomy Radiation Therapy.
Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposePencil beam scanning proton therapy enables highly conformal dose distributions and is increasingly used for postmastectomy radiation therapy (PMRT) to reduce cardiopulmonary exposure. However, implant-based reconstruction (IBR) in the setting of PMRT remains susceptible to capsular contracture, and the potential contribution of elevated linear energy transfer (LET) in pencil beam scanning has not been well characterized. This study aimed to investigate the combined effects of dose-LET and dose-averaged LET on capsular contracture after proton PMRT and to derive preliminary, exploratory volume cutoff values of dose-LET volume constraints (DLVCs). METHODS AND MATERIALS: We conducted a retrospective case-control study of patients with consecutive breast cancer who underwent mastectomy followed by IBR and conventionally fractionated proton PMRT (50 Gy in 25 fractions) between 2015 and 2021. Patients who developed Baker grades III to IV capsular contracture were identified and matched 1:2 with controls using nearest-neighbor matching based on clinical and pathologic variables. Dose-LET volume histograms (DLVHs) were calculated for peri-implant tissue (5-mm shell around the implant). Generalized linear mixed-effects regression was used to identify DLVH indices significantly associated with capsular contracture. Redundant indices were removed using Spearman correlation analysis. DLVCs were derived from receiver operating characteristic curve analysis and evaluated using a support vector machine-based normal tissue complication probability model with leave-one-out cross-validation.
resultsAmong 145 consecutive patients, 8 developed capsular contracture and were matched to 16 controls. Three independent DLVH indices were significantly associated with capsular contracture (P < .01): V (55.8 Gy [relative biological effectiveness {RBE} value = 1.1], 2.2 keV/μm), V (50.3 Gy [RBE value = 1.1], 5.4 keV/μm), and V (32.8 Gy [RBE value = 1.1], 0.9 keV/μm). After Benjamini-Hochberg false discovery rate correction across all 4096 DLVH indices, all 3 remained significant (q_Benjamini-Hochberg = 0.052). The corresponding DLVCs were V (55.8 Gy [RBE value = 1.1], 2.2 keV/μm) < 0.0017%, V (50.3 Gy [RBE value = 1.1], 5.4 keV/μm) < 0.0033%, and V (32.8 Gy [RBE value = 1.1], 0.9 keV/μm) > 96.98%. The support vector machine-based normal tissue complication probability model achieved an area under the receiver operating characteristic curve value of 0.867, with an accuracy of 91.7%, a sensitivity of 87.5%, and a specificity of 93.8%.
conclusionsCapsular contracture following proton PMRT is significantly associated with the combined effects of dose-LET and dose-averaged LET in peri-implant tissue. The derived DLVCs represent exploratory candidate dosimetric constraints that warrant further investigation and prospective validation in patients with breast cancer undergoing proton PMRT with IBR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.